CYP3A4 and cancer: CYP3A4 is involved in the metabolism of over 50% of clinically active drugs; thus, its overexpression can lead to reduced efficacy and the development of chemotherapeutic drug resistance, posing a major challenge for patients with cancer (Lehmann et al., 1998; Sevrioukova and Poulos., 2013).